RecruitingType 2 Diabetes MellitusT2DM
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Eligible age
18–75 yrs
Accepts
All genders
Locations
8 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellitus over 36 weeks.
Sponsor: Hanmi Pharmaceutical Company Limited
Where it's recruiting
Source: ClinicalTrials.gov · NCT07527650 · last updated 2026-05-26